By leveraging catheter-based delivery systems, transcatheter valve therapies enable the deployment of bioprosthetic replacements within diseased cardiac structures, significantly optimizing clinical outcomes for high-risk valvular patient cohorts. The ASEAN Transcatheter Heart Valves Market size is expected to reach US$ 79.4 million by 2033 from US$ 45.0 million in 2024. The market is...